Navigation Links
Oramed Pharmaceuticals to Present at Rodman & Renshaw Healthcare Conference (November 11, 2008; NYC)
Date:10/30/2008

JERUSALEM, October 30 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery systems, announced today that its Chief Executive Officer, Mr. Nadav Kidron, will be giving a company presentation at the 10th Annual Rodman & Renshaw Healthcare Conference at New York City's Palace Hotel on November 11. Mr. Kidron is scheduled to present from 4:05 - 4:30 in the Kennedy II Ballroom, located on the 4th floor of the hotel.

"The Rodman & Renshaw Conference will give Oramed an important platform to present the accomplishments we have achieved in our development of an oral insulin capsule and our unique position as a technology pioneer in the field of oral delivery solutions," said Kidron.

For more information about Rodman & Renshaw and the upcoming conference, please visit http://www.rodmanandrenshaw.com/conferences.

For more information about Oramed Pharmaceuticals, please visit http://www.oramed.com.

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research by top research scientists at Jerusalem's Hadassah Medical Center. The Company's corporate and R&D headquarters are based in Jerusalem.

For more information, please visit http://www.oramed.com

Forward-looking statements

Some of the statements contained in this press release are forward-looking statements which
'/>"/>

SOURCE Oramed Pharmaceticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Oramed Pharmaceuticals Partners With ETI Karle Clinical to Conduct Phase 2B Trials on Its Oral Insulin Capsule, ORMD 0801
2. Oramed Pharmaceuticals to Present Oral Insulin Trial Results at ADA Conference (June 6-10, San Francisco)
3. Israels Prestigious Presidents Conference to Feature Oramed Pharmaceuticals Revolutionary Oral Insulin Capsule
4. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
5. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and Provide a Clinical Program Update on November 6, 2008
6. Arena Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference
7. Indevus Pharmaceuticals to Present at Upcoming Investor Conferences
8. Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008
9. Memory Pharmaceuticals Provides Update on NASDAQ Listing Status
10. BioWa Announces License of Biowas Potelligent(R) Technology to KaloBios Pharmaceuticals
11. Potentia Pharmaceuticals to Present ASaP Phase I Clinical Trial Data for POT-4 at the American Academy of Ophthalmology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/16/2014)... The “Fluid Management & Visualization Systems Market”, ... with an analysis and forecast of value by ... warming and waste management. Along with this, the ... by applications and regions are also discussed in ... $19,285.5 million in 2013 and is expected to ...
(Date:11/15/2014)... The International Society for ... the society’s Governing Board has grown with the ... scientific officer and Dr. Charles Simonton, divisional vice ... Mr. Rowe and Dr. Simonton are both ... , Dr. Nabil Dib, ISCTR President stated, ...
(Date:11/15/2014)... November 14, 2014 New photonics entrepreneurs ... Startup Challenge 2015 , an opportunity to pitch their ... experts and venture capitalists. The annual competition is held ... Center in San Francisco, running 7-12 February and hosted ... photonics . , Cash prizes, including $10,000 for first ...
(Date:11/15/2014)... -- F. David Rollo , MD, Ph.D., FACC, FACNP ... Professional in the field of Medicine as a result ... Cell Point is a privately held biotechnology ... , Houston and ... ethylenedicysteine drug conjugate technology ("EC Technology"), In-Situ Hydrogel ("In ...
Breaking Biology Technology:Fluid Visualization Systems Market poised to reach $25,908.4 Million by 2018 - New Research Report by MarketsandMarkets 2Fluid Visualization Systems Market poised to reach $25,908.4 Million by 2018 - New Research Report by MarketsandMarkets 3Fluid Visualization Systems Market poised to reach $25,908.4 Million by 2018 - New Research Report by MarketsandMarkets 4International Society for Cardiovascular Translational Research Governing Board Adds Medical Industry Leaders 2New Photonics Entrepreneurs Need to Apply Now for SPIE Startup Challenge 2015 2New Photonics Entrepreneurs Need to Apply Now for SPIE Startup Challenge 2015 3F. David Rollo, MD, Ph.D., FACC, FACNP is recognized by Continental Who's Who as a Pinnacle Professional 2
... better predict general patterns of evolution, a University of ... surprising things about gene mutations that might one day ... disease. UH evolutionary biologist Timothy Cooper and ... "Negative Epistasis Between Beneficial Mutations in an Evolving Bacterial ...
... WESTBROOK, Maine, June 2, 2011 IDEXX Laboratories, Inc. (NASDAQ: ... in the William Blair & Company 31st Annual Growth Stock ... a presentation on the Company on Tuesday, June 14, 2011 ... Chicago, Illinois. Individuals can access the live audio webcast of ...
... Morphotek®, Inc., a subsidiary of Eisai Inc., announced today ... of MORAb-004 for the treatment of metastatic melanoma. The ... that specifically binds to endosialin/tumor endothelial marker-1 (TEM-1), as ... activity at two dosages. The trial is ...
Cached Biology Technology:Work by UH evolutionary biologist may one day help with chronic diseases 2Morphotek®, Inc. Announces Initiation of MORAb-004 Phase II Study in Melanoma 2Morphotek®, Inc. Announces Initiation of MORAb-004 Phase II Study in Melanoma 3
(Date:11/3/2014)... Researchers from Australia report that low birth weight and ... (OA)-related hip replacements in adulthood. Findings published in the ... & Research , indicate that low birth weight and ... arthroplasty due to OA as adults. , According ... of 25 are diagnosed with clinical OA. Symptoms of ...
(Date:11/2/2014)... was fascinating to put a flashlight up to our ... Washington University in St. Louis engineers are using a ... to improve imaging of cancerous tissues and to develop ... K. Beare Distinguished Professor of Biomedical Engineering at the ... novel time-reversal technology that allows researchers to better focus ...
(Date:10/31/2014)... Brazil was the world,s largest producer of cocoa. Chocolate ... 800, 000 ha region of rainforest in the state ... trees. Whereas the surrounding rainforest was a biodiversity hotspot, ... handful of seeds introduced in the mid 1700s, had ... scientist Gonçalo Pereira, "This scenario created a very romantic, ...
Breaking Biology News(10 mins):Preterm, low birth-weight babies may need new hips in adulthood 2Improving imaging of cancerous tissues by reversing time 2Scientists seek cure for devastating witches' broom disease of the chocolate tree 2Scientists seek cure for devastating witches' broom disease of the chocolate tree 3
... Product Development, teaming with,Ball Aerospace & Technologies Corp., ... a new thermal insulation. NASA has awarded,the team ... to develop and,commercialize this advanced thermal insulation., ... and exploration missions would preserve rocket fuels such ...
... Dr. Marie-Jolle Rochet, a research scientist at IFREMER (The ... been awarded the prestigious Pew Fellowship in Marine Conservation ... least harmful to the delicately balanced marine ecosystem. She ... encourage widespread use of that technique, and to further ...
... the Integrated Ocean Drilling Programs Nankai Trough Seismogenic ... Kii Peninsula today. The expedition science party, 26 ... 19, 2007, aboard the drilling vessel Chikyu, to ... of the Nankai Trough fault zone. The expedition ...
Cached Biology News:Colorado Engineering Firms Win NASA Grant to Develop Innovative Insulation for Next Generation Spacecraft - Super-Insulation May Allow Future Energy Efficient Appliances 22008 Pew Fellowship in Marine Conservation awarded to Dr. Marie-Joëlle Rochet from IFREMER 22008 Pew Fellowship in Marine Conservation awarded to Dr. Marie-Joëlle Rochet from IFREMER 32008 Pew Fellowship in Marine Conservation awarded to Dr. Marie-Joëlle Rochet from IFREMER 4Scientists obtain core samples from subsea fault system off Japan 2